WinstonWınston
Evolent Health logo

Evolent Health

EVH
11
Medical - Healthcare Information Services · Healthcare
Price
$5.81
+0.14 (+2.47%)
Market Cap
$653.5M
Winston Score
11
Winston is worried
Weak fundamentals across most pillars.

Share count rising — dilution

+32.7% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 86.1M (2021) → 114.2M (2025)

Evolent Health helps health insurance plans and hospital systems manage patients with complex, expensive medical conditions. The company focuses on specialty care areas like cancer treatment, heart disease, and musculoskeletal conditions, working with health plans as its main customers. It sits in the healthcare technology and services industry, acting as an outsourced partner that helps payers control costs and coordinate care for their sickest members.

Evolent makes money by charging health plans fees tied to the number of members it manages, often taking on some financial risk for the cost of that care. The company operates primarily in the United States and has grown largely through acquisitions, including its purchase of specialty care management firm NIA. Its competitive position depends on deep clinical data and established health plan relationships, but the business currently runs at a thin operating loss, and its main risk is that taking on medical cost risk can hurt results sharply if patient care expenses come in higher than expected.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+2.6% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+61.9% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

4.8%ownership

Declining

Insider ownership declining — could be dilution or selling

Cash Runway

~6 years

$166M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

$166M cash & investments at current burn rate

Growth context

Evolent Health is growing revenue at 3% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
12.5%
Thin — 12.5% gross margin
Operating Margin
-2.0%
Losing money on operations — -2.0%
ROCE
-0.7%
Weak — -0.7% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-21.3%
Shrinking sales (-21.3% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
0.1%
Thin free cash flow (0.1%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
2.48
Heavy debt load (2.48)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial